Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study
Titel:
Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study
Auteur:
Esteban, Emilio Modollel, Antonio de Sande, Luis González Palacio, Isabel Muñiz, Isabel Fernández, Yolanda Corral, Norberto Fra, Joaquin Sala, Marian Vieitez, Jose María Estrada, Enrique Lacave, AJ